Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 35 matching records.
35 results — page 1 of 2
- Level BClinical TrialPubMed
Allogeneic mesenchymal stem cell therapy combined with photobiomodulation for neonatal soft-tissue necrosis: A case report.
Clinical Trial on Chronic Wound, published in Curr Res Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
Curr Res Transl Med - Level DAnimal StudyPubMed
Mesenchymal Stem Cell Therapy Fails to Improve Fat Graft Retention: Cryopreserved and Cultured Syngeneic and Allogeneic Mesenchymal Stem Cells in a Rat Model.
Animal Study, published in Plast Reconstr Surg (2025) — summary generated from the PubMed abstract.
- 2025
Plast Reconstr Surg - Level BRandomized Controlled TrialPubMed
Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantation.
Randomized Controlled Trial with a reported sample of 31 on Immune Modulation, published in JHLT Open (2025) — summary generated from the PubMed abstract.
- 2025
- n = 31
JHLT Open2 citations - Level AMeta-analysisPubMed
Autologous Versus Allogeneic Adipose-Derived Mesenchymal Stem Cell Therapy for Knee Osteoarthritis: A Systematic Review, Pairwise and Network Meta-Analysis of Randomized Controlled Trials.
Meta-analysis on Knee Osteoarthritis, Osteoarthritis, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus - Level CProspective StudyPubMed
Bicomponent Cutaneous Cell Therapy for Early Burn Care: Manufacturing Homogeneity and Epidermis-Structuring Functions of Clinical Grade FE002-SK2 Allogeneic Dermal Progenitor Fibroblasts.
Prospective Study on Chronic Wound, Burns, published in Pharmaceutics (2025) — summary generated from the PubMed abstract.
- 2025
Pharmaceutics1 citations - Level DAnimal StudyPubMed
Allogeneic gene therapy with BMP-2-transduced mesenchymal stem cells combined with immunosuppression enhances bone healing.
Animal Study on Immune Modulation, published in Mol Ther (2025) — summary generated from the PubMed abstract.
- 2025
Mol Ther - Level AMeta-analysisEurope PMC
Mesenchymal stem cells added to second-line therapy improve response and failure-free survival in steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A meta-analys
Meta-analysis with a reported sample of 650 on Immune Modulation, published in Front Oncol (2025) — summary generated from the PubMed abstract.
- 2025
- n = 650
Front Oncol - Level BClinical TrialPubMed
Real-World Data as External Control in Assessing the Efficacy of Allogeneic Adipose-Derived Stem Cells Therapy for Advanced Chronic Kidney Disease.
Clinical Trial on Chronic Kidney Disease, published in Clin Transl Sci (2025) — summary generated from the PubMed abstract.
- 2025
Clin Transl Sci1 citations - Level CCase Report / SeriesPubMed
Allogeneic mesenchymal stromal cell therapy for nonregenerative anemia in a FeLV-infected cat: a case report.
Case Report / Series on Systemic / IV, published in Cytotherapy (2025) — summary generated from the PubMed abstract.
- 2025
Cytotherapy - Level DAnimal StudyEurope PMC
Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironment
Animal Study on Immune Modulation, published in Cytotherapy (2024) — summary generated from the PubMed abstract.
- 2024
Cytotherapy7 citations - Level CCohort StudyPubMed
Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn's disease.
Cohort Study with a reported sample of 36 on Scar, Autoimmune Research, published in Clin Res Hepatol Gastroenterol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 36
Clin Res Hepatol Gastroenterol - Level DLaboratory StudyEurope PMC
Banked Primary Progenitor Cells for Allogeneic Intervertebral Disc (IVD) Therapy: Preclinical Qualification and Functional Optimization within a Cell Spheroid Formulation Process
Laboratory Study on Back Pain, Disc Degeneration, published in Pharmaceutics (2024) — summary generated from the PubMed abstract.
- 2024
Pharmaceutics - Level CProspective StudyPubMed
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Prospective Study with a reported sample of 46 on Immune Modulation, published in Ann Hematol (2023) — summary generated from the PubMed abstract.
- 2023
- n = 46
Ann Hematol - Level BClinical TrialPubMed
Suicide gene therapy using allogeneic adipose tissue-derived mesenchymal stem cell gene delivery vehicles in recurrent glioblastoma multiforme: a first-in-human, dose-escalation, phase I clinical trial.
Clinical Trial with a reported sample of 3, published in J Transl Med (2023) — summary generated from the PubMed abstract.
- 2023
- n = 3
J Transl Med19 citations - Level BRandomized Controlled TrialPubMed
Allogeneic mesenchymal stem cell therapy for dry eye disease in patients with Sjögren's syndrome: A randomized clinical trial.
Randomized Controlled Trial with a reported sample of 20 on Meniscus Injury, published in Ocul Surf (2023) — summary generated from the PubMed abstract.
- 2023
- n = 20
Ocul Surf30 citations - Level AMeta-analysisEurope PMC
Clinical Evaluation of Autologous and Allogeneic Stem Cell Therapy for Intrauterine Adhesions: A Systematic Review and Meta-Analysis
Meta-analysis with a reported sample of 116, published in Front Immunol (2022) — summary generated from the PubMed abstract.
- 2022
- n = 116
Front Immunol14 citations - Level CProspective StudyEurope PMC
Polydactyly-derived allogeneic chondrocyte cell-sheet transplantation with high tibial osteotomy as regenerative therapy for knee osteoarthritis
Prospective Study on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in NPJ Regen Med (2022) — summary generated from the PubMed abstract.
- 2022
NPJ Regen Med22 citations - Level BClinical TrialPubMed
Development of Allogeneic Stem Cell-Based Platform for Delivery and Potentiation of Oncolytic Virotherapy.
Clinical Trial, published in Cancers (Basel) (2022) — summary generated from the PubMed abstract.
- 2022
Cancers (Basel)5 citations - Level BClinical TrialPubMed
Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series.
Clinical Trial with a reported sample of 11 on Immune Modulation, Autoimmune Research, published in Colorectal Dis (2021) — summary generated from the PubMed abstract.
- 2021
- n = 11
Colorectal Dis23 citations - Level DAnimal StudyPubMed
Identification of alpha-enolase as a potential immunogenic molecule during allogeneic transplantation of human adipose-derived mesenchymal stromal cells.
Animal Study, published in Cytotherapy (2021) — summary generated from the PubMed abstract.
- 2021
Cytotherapy3 citations - Level CProspective StudyPubMed
Cutaneous wound healing: canine allogeneic ASC therapy.
Prospective Study on Chronic Wound, published in Stem Cell Res Ther (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cell Res Ther21 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells
Narrative Review on Chronic Kidney Disease, published in Stem Cells Int (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cells Int34 citations - Level DLaboratory StudyPubMed
Outcome of Allogeneic Adult Stem Cell Therapy in Dogs Suffering from Osteoarthritis and Other Joint Defects.
Laboratory Study on Osteoarthritis, published in Stem Cells Int (2018) — summary generated from the PubMed abstract.
- 2018
Stem Cells Int50 citations - Level DAnimal StudyEurope PMC
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice
Animal Study on Systemic / IV, published in Cancer Immunol Immunother (2018) — summary generated from the PubMed abstract.
- 2018
Cancer Immunol Immunother21 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406